Smith & Nephew plc (LON:SN)‘s stock had its “hold” rating reaffirmed by equities research analysts at Deutsche Bank AG in a research report issued on Friday, July 28th, Marketbeat reports. They currently have a GBX 1,200 ($15.58) price objective on the stock. Deutsche Bank AG’s price objective suggests a potential downside of 12.85% from the company’s current price.
SN has been the topic of a number of other reports. Citigroup Inc. reaffirmed a “sell” rating and set a GBX 1,160 ($15.06) price objective on shares of Smith & Nephew plc in a report on Monday, July 10th. J P Morgan Chase & Co cut their price target on shares of Smith & Nephew plc from GBX 1,345 ($17.46) to GBX 1,280 ($16.62) and set a “neutral” rating on the stock in a report on Monday, May 8th. Berenberg Bank reissued a “hold” rating and issued a GBX 1,300 ($16.88) price target on shares of Smith & Nephew plc in a report on Tuesday, July 18th. HSBC Holdings plc reaffirmed a “hold” rating and set a GBX 1,320 ($17.14) price objective on shares of Smith & Nephew plc in a report on Wednesday, April 26th. Finally, Credit Suisse Group upped their price objective on shares of Smith & Nephew plc from GBX 1,160 ($15.06) to GBX 1,200 ($15.58) and gave the company a “neutral” rating in a report on Monday, May 8th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of GBX 1,289.25 ($16.74).
Shares of Smith & Nephew plc (LON SN) traded up 0.29% during trading on Friday, reaching GBX 1381.00. 1,176,160 shares of the company’s stock were exchanged. The company has a 50 day moving average price of GBX 1,326.26 and a 200-day moving average price of GBX 1,284.23. Smith & Nephew plc has a 52-week low of GBX 1,064.91 and a 52-week high of GBX 1,390.00. The company’s market capitalization is GBX 12.09 billion.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by BBNS and is the sole property of of BBNS. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/smith-nephew-plcs-sn-hold-rating-reaffirmed-at-deutsche-bank-ag-updated-updated/1316044.html.
In related news, insider Virginia Bottomley acquired 223 shares of the company’s stock in a transaction dated Wednesday, August 16th. The stock was purchased at an average price of GBX 1,380 ($17.92) per share, with a total value of £3,077.40 ($3,995.07).
Smith & Nephew plc Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with our FREE daily email newsletter.